BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7507263)

  • 21. [Treatment of adult acute lymphoblastic leukemia with Ad-VP-L regimen].
    Umeda M; Shikoshi K; Anno S; Su CY; Shirai T
    Rinsho Ketsueki; 1991 Jan; 32(1):6-10. PubMed ID: 2020119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
    Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
    Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S
    Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
    Ho CL; Chen YC; Kao WY; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia.
    Hurtado R; Candelaria M; Vargas F; Majluf A; Bolaños F; Labardini JR
    Stem Cells; 1995 Mar; 13(2):112-22. PubMed ID: 7787778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
    Martino R; Bellido M; Brunet S; Altés A; Sureda A; Guárdia R; Aventín A; Nomdedéu JF; Domingo-Albós A; Sierra J
    Haematologica; 1999 Jun; 84(6):505-10. PubMed ID: 10366793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience.
    Pastore D; Specchia G; Carluccio P; Liso A; Mestice A; Rizzi R; Greco G; Buquicchio C; Liso V
    Ann Hematol; 2003 Apr; 82(4):231-5. PubMed ID: 12707726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A late phase II study of idarubicin hydrochloride in adult patients with acute lymphocytic leukemia. Idarubicin Study Group].
    Masaoka T; Ogawa M; Yamada K; Kimura K
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2007-14. PubMed ID: 8215475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
    Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
    Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Finnish Leukaemia Group.
    Eur J Haematol; 1992 Feb; 48(2):75-82. PubMed ID: 1547879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.
    Takeuchi J; Kyo T; Naito K; Sao H; Takahashi M; Miyawaki S; Kuriyama K; Ohtake S; Yagasaki F; Murakami H; Asou N; Ino T; Okamoto T; Usui N; Nishimura M; Shinagawa K; Fukushima T; Taguchi H; Morii T; Mizuta S; Akiyama H; Nakamura Y; Ohshima T; Ohno R
    Leukemia; 2002 Jul; 16(7):1259-66. PubMed ID: 12094249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The results of using differentiated programs of therapy in acute lymphoblastic leukemia in adults].
    Volkova MA; Perilov AA; Kaletin GI; Tupitsyn NN; Frenkel' MA; Fleĭshman EV
    Ter Arkh; 1991; 63(7):109-11. PubMed ID: 1788786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 37. Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.
    Arcese W; Meloni G; Giona F; Vegna ML; Testi AM; Annino L; Iori AP; Carotenuto M; Resegotti L; Madon E
    Bone Marrow Transplant; 1991; 7 Suppl 2():38. PubMed ID: 1878711
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia.
    Weiss M; Telford P; Kempin S; Kritz A; Sogoloff H; Gee T; Berman E; Scheinberg D; Little C; Gaynor J
    Leukemia; 1993 Jun; 7(6):832-7. PubMed ID: 8501978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
    Carella AM
    Haematologica; 1992; 77(4):348-51. PubMed ID: 1358772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.